IRIS Accounts Production v25.1.4.42 13652693 director 1.10.23 30.9.24 30.9.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh136526932023-09-30136526932024-09-30136526932023-10-012024-09-30136526932022-09-30136526932022-10-012023-09-30136526932023-09-3013652693ns15:EnglandWales2023-10-012024-09-3013652693ns14:PoundSterling2023-10-012024-09-3013652693ns10:Director12023-10-012024-09-3013652693ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3013652693ns10:SmallEntities2023-10-012024-09-3013652693ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3013652693ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3013652693ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3013652693ns10:FullAccounts2023-10-012024-09-3013652693ns10:OrdinaryShareClass12023-10-012024-09-3013652693ns10:RegisteredOffice2023-10-012024-09-3013652693ns5:CurrentFinancialInstruments2024-09-3013652693ns5:CurrentFinancialInstruments2023-09-3013652693ns5:ShareCapital2024-09-3013652693ns5:ShareCapital2023-09-3013652693ns5:RetainedEarningsAccumulatedLosses2024-09-3013652693ns5:RetainedEarningsAccumulatedLosses2023-09-3013652693ns5:PlantMachinery2023-10-012024-09-3013652693ns5:ComputerEquipment2023-10-012024-09-3013652693ns5:PlantMachinery2023-09-3013652693ns5:ComputerEquipment2023-09-3013652693ns5:PlantMachinery2024-09-3013652693ns5:ComputerEquipment2024-09-3013652693ns5:PlantMachinery2023-09-3013652693ns5:ComputerEquipment2023-09-3013652693ns5:AdditionsToInvestmentsns5:ListedExchangeTraded2024-09-3013652693ns5:ListedExchangeTradedns5:DisposalsRepaymentsInvestments2024-09-3013652693ns5:RevaluationsIncreaseDecreaseInInvestmentsns5:ListedExchangeTraded2024-09-3013652693ns5:CostValuationns5:ListedExchangeTraded2024-09-3013652693ns5:ListedExchangeTraded2024-09-3013652693ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3013652693ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3013652693ns5:DeferredTaxation2023-09-3013652693ns5:DeferredTaxation2023-10-012024-09-3013652693ns5:DeferredTaxation2024-09-3013652693ns10:OrdinaryShareClass12024-09-30
REGISTERED NUMBER: 13652693 (England and Wales)















SCL HEALTH LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2024






SCL HEALTH LIMITED (REGISTERED NUMBER: 13652693)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 30 SEPTEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


SCL HEALTH LIMITED

COMPANY INFORMATION
for the Year Ended 30 SEPTEMBER 2024







DIRECTOR: Dr M P Motwani





REGISTERED OFFICE: Elm Tree Cottage
12 Showell Road
Lower Penn
Wolverhampton
WV4 4UA





REGISTERED NUMBER: 13652693 (England and Wales)





ACCOUNTANTS: Wallace Crooke
College House
St Leonards Close
Bridgnorth
Shropshire
WV16 4EJ

SCL HEALTH LIMITED (REGISTERED NUMBER: 13652693)

BALANCE SHEET
30 SEPTEMBER 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,028 1,343
Investments 5 31,107 -
33,135 1,343

CURRENT ASSETS
Debtors 6 295 200
Cash at bank 200,812 130,145
201,107 130,345
CREDITORS
Amounts falling due within one year 7 36,210 23,140
NET CURRENT ASSETS 164,897 107,205
TOTAL ASSETS LESS CURRENT
LIABILITIES

198,032

108,548

PROVISIONS FOR LIABILITIES 8 648 255
NET ASSETS 197,384 108,293

CAPITAL AND RESERVES
Called up share capital 9 1 1
Retained earnings 197,383 108,292
SHAREHOLDERS' FUNDS 197,384 108,293

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

SCL HEALTH LIMITED (REGISTERED NUMBER: 13652693)

BALANCE SHEET - continued
30 SEPTEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 10 June 2025 and were signed by:





Dr M P Motwani - Director


SCL HEALTH LIMITED (REGISTERED NUMBER: 13652693)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 30 SEPTEMBER 2024

1. STATUTORY INFORMATION

SCL Health Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

The company's financial statements are individual entity financial statements.

The company's financial statements are presented in Sterling and all values are rounded to the nearest pound.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery - 20% on cost
Computer equipment - 20% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

SCL HEALTH LIMITED (REGISTERED NUMBER: 13652693)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 30 SEPTEMBER 2024

4. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 October 2023 200 1,529 1,729
Additions - 2,188 2,188
Disposals - (1,199 ) (1,199 )
At 30 September 2024 200 2,518 2,718
DEPRECIATION
At 1 October 2023 80 306 386
Charge for year 40 504 544
Eliminated on disposal - (240 ) (240 )
At 30 September 2024 120 570 690
NET BOOK VALUE
At 30 September 2024 80 1,948 2,028
At 30 September 2023 120 1,223 1,343

5. FIXED ASSET INVESTMENTS
Listed
investments
£   
COST OR VALUATION
Additions 31,392
Disposals (1,665 )
Revaluations 1,380
At 30 September 2024 31,107
NET BOOK VALUE
At 30 September 2024 31,107

Cost or valuation at 30 September 2024 is represented by:

Listed
investments
£   
Valuation in 2024 1,380
Cost 29,727
31,107

If fixed asset investments had not been revalued they would have been included at the following historical cost:

2024 2023
£    £   
Cost 29,727 -

Fixed asset investments were valued on an open market basis on 30 September 2024 by the Director .

SCL HEALTH LIMITED (REGISTERED NUMBER: 13652693)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 30 SEPTEMBER 2024

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Other debtors 295 200

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors (1 ) -
Taxation and social security 26,495 14,546
Other creditors 9,716 8,594
36,210 23,140

8. PROVISIONS FOR LIABILITIES
2024 2023
£    £   
Deferred tax 648 255

Deferred
tax
£   
Balance at 1 October 2023 255
Provided during year 393
Balance at 30 September 2024 648

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2024 2023
value: £    £   
1 Ordinary o1 1 1